Express News | Virios Therapeutics Shares Are Trading Higher After the Company Announced the Publication of an International Patent Titled "Valacyclovir and Celecoxib for the Treatment of Alzheimer's and COVID-19"

Moomoo 24/7Apr 1 11:21 ET

Virios Therapeutics Announces Publication Of International Patent For IMC-2 Covering Antiviral Treatment Of Long-COVID

- New patent would extend coverage and expand potential value of Virios' antiviral pipeline globally –- Active Long-COVID characterized by immune dysfunction leading to recurrent herpesviruses reactiv

BenzingaMar 26 09:17 ET

12 Health Care Stocks Moving In Friday's Intraday Session

GainersIMAC Hldgs (NASDAQ:BACK) shares moved upwards by 91.5% to $2.47 during Friday's regular session. The market value of their outstanding shares is at $2.8 million. Virios Therapeutics (NASDAQ:VIR

BenzingaMar 22 13:31 ET

12 Health Care Stocks Moving In Thursday's Pre-Market Session

GainersYield10 Bioscience (NASDAQ:YTEN) stock increased by 133.7% to $0.57 during Thursday's pre-market session. The market value of their outstanding shares is at $6.8 million. Immunovant (NASDAQ:IMV

BenzingaMar 21 09:05 ET

Virios Therapeutics: A Hold Rating With a New Price Target Amidst Clinical and Financial Challenges

TipRanksMar 6 06:38 ET

Virios Therapeutics Reports Q4 Results

Seeking AlphaMar 1 10:49 ET